SCHEMBL3120976

SCHEMBL3120976

Cc1nc(C(N)=O)cc2c1CCCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.41
NPC1 O15118 3/20 0.41
MAPT P10636 2/20 0.41
ATM Q13315 2/20 0.41
HTT P42858 1/20 0.41
SLC9A1 P19634 1/20 0.40
LMNA P02545 1/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
DPP4 P27487 1/20 0.35
DPP8 Q6V1X1 1/20 0.35
NLRP3 Q96P20 1/20 0.34
POLB P06746 2/20 0.34
GRM2 Q14416 3/20 0.34
EEF2K O00418 2/20 0.34
ALDH1A1 P00352 2/20 0.34
RAB9A P51151 2/20 0.34
ACHE P22303 1/20 0.34
KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2624121 0.81 LMNA (0.40) KDM4ENPC1MAPTSLC9A1LMNA
SCHEMBL19998979 0.78 NOS3 (0.56) KDM4ENPC1MAPTHTTLMNA
SCHEMBL1971763 0.73 NOS3 (0.53) KDM4ENPC1HTTNOS3NOS1
SCHEMBL20416971 0.72 STAT3 (0.43) KDM4ENPC1MAPTLMNANOS3
SCHEMBL11942291 0.71 LMNA (0.47) HTTLMNADPP4DPP8POLB
SCHEMBL3999989 0.69 NOS3 (0.46) KDM4ELMNANOS3NOS1NOS2
SCHEMBL8249959 0.69 ALDH1A1 (0.44) KDM4ENPC1MAPTNLRP3ALDH1A1
SCHEMBL18510113 0.69 KDM4E (0.44) KDM4ENPC1MAPTNOS3NOS1
SCHEMBL16751985 0.68 LMNA (0.44) LMNADPP4DPP8POLBGRM2
SCHEMBL18248727 0.68 NOS3 (0.52) KDM4ENPC1MAPTLMNANOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US claimed
WO-2010034796-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO claimed
US-8916599-B2 1H-benz imidazole-5-carboxamides as anti-inflammatory agents OREXO AB (SE) 2014-12-23 US disclosed
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
WO-2010034796-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents MAPRE2, MAPRE1, H1-4 KDM4E 140/4885NPC1 4650/4885MAPT 480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.